1887

Abstract

is a multidrug-resistant opportunistic pathogen that persists in the hospital environment and causes various clinical infections, primarily affecting immunocompromised patients. has evolved a wide range of mechanisms to compete with neighbouring bacteria. One such competition strategy depends on small secreted peptides called microcins, which exert antimicrobial effects in a contact-independent manner. Here, we report that ATCC 17978 (AB17978) encodes the class II microcin 17 978 (Mcc17978) with antimicrobial activity against closely related , and surprisingly, also strains. We identified the genetic locus encoding the Mcc17978 system in AB17978. Using classical bacterial genetic approaches, we determined that the molecular receptor of Mcc17978 in is the iron-catecholate transporter Fiu, and in is Fiu’s homolog, PiuA. In bacteria, the Ferric uptake regulator (Fur) positively regulates siderophore systems and microcin systems under iron-deprived environments. We found that the Mcc17978 system is upregulated under low-iron conditions commonly found in the host environment and identified a putative Fur binding site upstream of the gene. When we tested the antimicrobial activity of Mcc17978 under different levels of iron availability, we observed that low iron levels not only triggered transcriptional induction of the microcin, but also led to enhanced microcin activity. Taken together, our findings suggest that may utilize microcins to compete with other microbes for resources during infection.

Funding
This study was supported by the:
  • The City College Of New York (Award Startup)
    • Principle Award Recipient: StefanPukatzki
  • National Institutes of Health (Award R01AI139103)
    • Principle Award Recipient: StefanPukatzki
  • Blank Family Foundation (Award Startup)
    • Principle Award Recipient: StefanPukatzki
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.001346
2023-06-07
2024-05-04
Loading full text...

Full text loading...

/deliver/fulltext/micro/169/6/mic001346.html?itemId=/content/journal/micro/10.1099/mic.0.001346&mimeType=html&fmt=ahah

References

  1. Falagas ME, Karveli EA. World Wide Web resources on antimicrobial resistance. Clin Infect Dis 2006; 43:630–633 [View Article] [PubMed]
    [Google Scholar]
  2. Dexter C, Murray GL, Paulsen IT, Peleg AY. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev Anti Infect Ther 2015; 13:567–573 [View Article] [PubMed]
    [Google Scholar]
  3. Farrow JM, Wells G, Pesci EC, Cascales E. Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR. PLoS ONE 2018; 13:e0205638 [View Article] [PubMed]
    [Google Scholar]
  4. Short FL, Liu Q, Shah B, Clift HE, Naidu V et al. The Acinetobacter baumannii disinfectant resistance protein, AmvA, is a spermidine and spermine efflux pump. Commun Biol 2021; 4:1114 [View Article] [PubMed]
    [Google Scholar]
  5. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46:1254–1263 [View Article] [PubMed]
    [Google Scholar]
  6. Miller DP, Wang Q, Weinberg A, Lamont RJ. Transcriptome analysis of Porphyromonas gingivalis and Acinetobacter baumannii in polymicrobial communities. Mol Oral Microbiol 2018; 33:364–377 [View Article] [PubMed]
    [Google Scholar]
  7. Cotter PD, Ross RP, Hill C. Bacteriocins - a viable alternative to antibiotics?. Nat Rev Microbiol 2013; 11:95–105 [View Article] [PubMed]
    [Google Scholar]
  8. Le NH, Pinedo V, Lopez J, Cava F, Feldman MF. Killing of Gram-negative and Gram-positive bacteria by a bifunctional cell wall-targeting T6SS effector. Proc Natl Acad Sci 2021; 118:e2106555118 [View Article] [PubMed]
    [Google Scholar]
  9. Basler M, Ho BT, Mekalanos JJ. Tit-for-tat: type VI secretion system counterattack during bacterial cell-cell interactions. Cell 2013; 152:884–894 [View Article] [PubMed]
    [Google Scholar]
  10. Carruthers MD, Nicholson PA, Tracy EN, Munson RS. Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition. PLoS One 2013; 8:e59388 [View Article] [PubMed]
    [Google Scholar]
  11. Weber BS, Miyata ST, Iwashkiw JA, Mortensen BL, Skaar EP et al. Genomic and functional analysis of the type VI secretion system in Acinetobacter. PLoS One 2013; 8:e55142 [View Article] [PubMed]
    [Google Scholar]
  12. Repizo GD, Gagné S, Foucault-Grunenwald M-L, Borges V, Charpentier X et al. Differential Role of the T6SS in Acinetobacter baumannii virulence. PLoS One 2015; 10:e0138265 [View Article] [PubMed]
    [Google Scholar]
  13. Simons A, Alhanout K, Duval RE. Bacteriocins, antimicrobial peptides from bacterial origin: overview of their biology and their impact against multidrug-resistant bacteria. Microorganisms 2020; 8:639 [View Article] [PubMed]
    [Google Scholar]
  14. Cole TJ, Parker JK, Feller AL, Wilke CO, Davies BW. Evidence for widespread class II microcins in Enterobacterales Genomes. Appl Environ Microbiol 2022; 88:e0148622 [View Article] [PubMed]
    [Google Scholar]
  15. Duquesne S, Destoumieux-Garzón D, Peduzzi J, Rebuffat S. Microcins, gene-encoded antibacterial peptides from enterobacteria. Nat Prod Rep 2007; 24:708–734 [View Article] [PubMed]
    [Google Scholar]
  16. Telhig S, Ben Said L, Zirah S, Fliss I, Rebuffat S. Bacteriocins to thwart bacterial resistance in gram negative bacteria. Front Microbiol 2020; 11:586433 [View Article] [PubMed]
    [Google Scholar]
  17. Gérard F, Pradel N, Wu L-F. Bactericidal activity of colicin V is mediated by an inner membrane protein, SdaC, of Escherichia coli. J Bacteriol 2005; 187:1945–1950 [View Article] [PubMed]
    [Google Scholar]
  18. Morin N, Lanneluc I, Connil N, Cottenceau M, Pons AM et al. Mechanism of bactericidal activity of microcin L in Escherichia coli and Salmonella enterica. Antimicrob Agents Chemother 2011; 55:997–1007 [View Article] [PubMed]
    [Google Scholar]
  19. Corsini G, Karahanian E, Tello M, Fernandez K, Rivero D et al. Purification and characterization of the antimicrobial peptide microcin N. FEMS Microbiol Lett 2010; 312:119–125 [View Article] [PubMed]
    [Google Scholar]
  20. Zhao Z, Orfe LH, Liu J, Lu S-Y, Besser TE et al. Microcin PDI regulation and proteolytic cleavage are unique among known microcins. Sci Rep 2017; 7:42529 [View Article] [PubMed]
    [Google Scholar]
  21. Zschüttig A, Zimmermann K, Blom J, Goesmann A, Pöhlmann C et al. Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10. PLoS One 2012; 7:e33351 [View Article] [PubMed]
    [Google Scholar]
  22. Rodríguez E, Gaggero C, Laviña M. The structural gene for microcin H47 encodes a peptide precursor with antibiotic activity. Antimicrob Agents Chemother 1999; 43:2176–2182 [View Article] [PubMed]
    [Google Scholar]
  23. Rodríguez E, Laviña M. The proton channel is the minimal structure of ATP synthase necessary and sufficient for microcin h47 antibiotic action. Antimicrob Agents Chemother 2003; 47:181–187 [View Article] [PubMed]
    [Google Scholar]
  24. Bieler S, Silva F, Soto C, Belin D. Bactericidal activity of both secreted and nonsecreted microcin E492 requires the mannose permease. J Bacteriol 2006; 188:7049–7061 [View Article] [PubMed]
    [Google Scholar]
  25. Palmer JD, Mortzfeld BM, Piattelli E, Silby MW, McCormick BA et al. Microcin H47: a class IIb microcin with potent activity against multidrug resistant Enterobacteriaceae. ACS Infect Dis 2020; 6:672–679 [View Article] [PubMed]
    [Google Scholar]
  26. Pons AM, Zorn N, Vignon D, Delalande F, Van Dorsselaer A et al. Microcin E492 is an unmodified peptide related in structure to colicin V. Antimicrob Agents Chemother 2002; 46:229–230 [View Article] [PubMed]
    [Google Scholar]
  27. Patzer SI, Baquero MR, Bravo D, Moreno F, Hantke K. The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology 2003; 149:2557–2570 [View Article] [PubMed]
    [Google Scholar]
  28. Parker JK, Davies BW. Microcins reveal natural mechanisms of bacterial manipulation to inform therapeutic development. Microbiology 2022; 168: [View Article] [PubMed]
    [Google Scholar]
  29. Wandersman C, Delepelaire P. Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol 2004; 58:611–647 [View Article] [PubMed]
    [Google Scholar]
  30. Machuca A, Pereira G, Aguiar A, Milagres AMF. Metal-chelating compounds produced by ectomycorrhizal fungi collected from pine plantations. Lett Appl Microbiol 2007; 44:7–12 [View Article] [PubMed]
    [Google Scholar]
  31. Grinter R, Lithgow T. The structure of the bacterial iron-catecholate transporter Fiu suggests that it imports substrates via a two-step mechanism. J Biol Chem 2019; 294:19523–19534 [View Article] [PubMed]
    [Google Scholar]
  32. de Lorenzo V, Pugsley AP. Microcin E492, a low-molecular-weight peptide antibiotic which causes depolarization of the Escherichia coli cytoplasmic membrane. Antimicrob Agents Chemother 1985; 27:666–669 [View Article] [PubMed]
    [Google Scholar]
  33. Destoumieux-Garzón D, Thomas X, Santamaria M, Goulard C, Barthélémy M et al. Microcin E492 antibacterial activity: evidence for a TonB-dependent inner membrane permeabilization on Escherichia coli. Mol Microbiol 2003; 49:1031–1041 [View Article] [PubMed]
    [Google Scholar]
  34. Biéler S, Silva F, Belin D. The polypeptide core of microcin E492 stably associates with the mannose permease and interferes with mannose metabolism. Res Microbiol 2010; 161:706–710 [View Article] [PubMed]
    [Google Scholar]
  35. Huang K, Zeng J, Liu X, Jiang T, Wang J. Structure of the mannose phosphotransferase system (man-PTS) complexed with microcin E492, a pore-forming bacteriocin. Cell Discov 2021; 7:20 [View Article] [PubMed]
    [Google Scholar]
  36. Trujillo M, Rodríguez E, Laviña M. ATP synthase is necessary for microcin H47 antibiotic action. Antimicrob Agents Chemother 2001; 45:3128–3131 [View Article] [PubMed]
    [Google Scholar]
  37. Rodríguez E, Laviña M. Genetic analysis of microcin H47 immunity. Can J Microbiol 1998; 44:692–697 [View Article] [PubMed]
    [Google Scholar]
  38. Fang CM, Wang JY, Chinchilla M, Levine MM, Blackwelder WC et al. Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors. Infect Immun 2008; 76:4422–4430 [View Article] [PubMed]
    [Google Scholar]
  39. Marcoleta AE, Gutiérrez-Cortez S, Hurtado F, Argandoña Y, Corsini G et al. The Ferric uptake regulator (Fur) and iron availability control the production and maturation of the antibacterial peptide microcin E492. PLoS One 2018; 13:e0200835 [View Article] [PubMed]
    [Google Scholar]
  40. Massip C, Oswald E. Siderophore-Microcins in Escherichia coli: determinants of digestive colonization, the first step toward virulence. Front Cell Infect Microbiol 2020; 10:381 [View Article] [PubMed]
    [Google Scholar]
  41. Eijkelkamp BA, Hassan KA, Paulsen IT, Brown MH. Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions. BMC Genomics 2011; 12:126 [View Article] [PubMed]
    [Google Scholar]
  42. Guan L, Liu Q, Li C, Zhang Y. Development of a Fur-dependent and tightly regulated expression system in Escherichia coli for toxic protein synthesis. BMC Biotechnol 2013; 13:25 [View Article] [PubMed]
    [Google Scholar]
  43. Bagg A, Neilands JB. Ferric uptake regulation protein acts as a repressor, employing iron (II) as a cofactor to bind the operator of an iron transport operon in Escherichia coli. Biochemistry 1987; 26:5471–5477 [View Article] [PubMed]
    [Google Scholar]
  44. Weinberg ED. Iron and susceptibility to infectious disease. Science 1974; 184:952–956 [View Article] [PubMed]
    [Google Scholar]
  45. Miethke M, Marahiel MA. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 2007; 71:413–451 [View Article] [PubMed]
    [Google Scholar]
  46. Ratledge C. Iron metabolism and infection. Food Nutr Bull 2007; 28:S515–23 [View Article] [PubMed]
    [Google Scholar]
  47. Sheldon JR, Laakso HA, Heinrichs DE, Kudva IT, Cornick NA. Iron acquisition strategies of bacterial pathogens. Microbiol Spectr 2016; 4: [View Article] [PubMed]
    [Google Scholar]
  48. Sheldon JR, Skaar EP. Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence. PLoS Pathog 2020; 16:e1008995 [View Article] [PubMed]
    [Google Scholar]
  49. Hasan T, Choi CH, Oh MH. Genes Involved in the biosynthesis and transport of acinetobactin in Acinetobacter baumannii. Genomics Inform 2015; 13:2–6 [View Article] [PubMed]
    [Google Scholar]
  50. Penwell WF, Actis LA. Isolation and characterization of the acinetobactin and baumannoferrin siderophores produced by Acinetobacter baumannii. Methods Mol Biol 2019; 1946:259–270 [View Article] [PubMed]
    [Google Scholar]
  51. Hamidian M, Hall RM. Dissemination of novel Tn7 family transposons carrying genes for synthesis and uptake of fimsbactin siderophores among Acinetobacter baumannii isolates. Microb Genom 2021; 7:mgen000548 [View Article] [PubMed]
    [Google Scholar]
  52. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 2007; 21:601–614 [View Article] [PubMed]
    [Google Scholar]
  53. Weber BS, Ly PM, Irwin JN, Pukatzki S, Feldman MF. A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii. Proc Natl Acad Sci 2015; 112:9442–9447 [View Article] [PubMed]
    [Google Scholar]
  54. Lucidi M, Runci F, Rampioni G, Frangipani E, Leoni L et al. New shuttle vectors for gene cloning and expression in multidrug-resistant Acinetobacter species. Antimicrob Agents Chemother 2018; 62:e02480-17 [View Article] [PubMed]
    [Google Scholar]
  55. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983; 166:557–580 [View Article] [PubMed]
    [Google Scholar]
  56. Hanahan D, Jessee J, Bloom FR. Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol 1991; 204:63–113 [View Article] [PubMed]
    [Google Scholar]
  57. Yildirim S, Thompson MG, Jacobs AC, Zurawski DV, Kirkup BC. Evaluation of parameters for high efficiency transformation of Acinetobacter baumannii. Sci Rep 2016; 6:22110 [View Article] [PubMed]
    [Google Scholar]
  58. Tucker AT, Nowicki EM, Boll JM, Knauf GA, Burdis NC et al. Defining gene-phenotype relationships in Acinetobacter baumannii through one-step chromosomal gene inactivation. mBio 2014; 5:e01313-14 [View Article] [PubMed]
    [Google Scholar]
  59. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci 2000; 97:6640–6645 [View Article] [PubMed]
    [Google Scholar]
  60. Miller J. H.(1972) Experiments in Molecular Genetics NY: ColdSpring Harbor Laboratory Cold Spring Harbor; 1978 pp 328–330
    [Google Scholar]
  61. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 2012; 9:676–682 [View Article] [PubMed]
    [Google Scholar]
  62. Di Venanzio G, Moon KH, Weber BS, Lopez J, Ly PM et al. Multidrug-resistant plasmids repress chromosomally encoded T6SS to enable their dissemination. Proc Natl Acad Sci 2019; 116:1378–1383 [View Article] [PubMed]
    [Google Scholar]
  63. Smits SHJ, Schmitt L, Beis K. Self-immunity to antibacterial peptides by ABC transporters. FEBS Lett 2020; 594:3920–3942 [View Article] [PubMed]
    [Google Scholar]
  64. Azpiroz MF, Laviña M. Involvement of enterobactin synthesis pathway in production of microcin H47. Antimicrob Agents Chemother 2004; 48:1235–1241 [View Article] [PubMed]
    [Google Scholar]
  65. Moynié L, Luscher A, Rolo D, Pletzer D, Tortajada A et al. Structure and function of the PiuA and PirA siderophore-drug Receptors from Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob Agents Chemother 2017; 61:e02531-16 [View Article] [PubMed]
    [Google Scholar]
  66. Strahsburger E, Baeza M, Monasterio O, Lagos R. Cooperative uptake of microcin E492 by receptors FepA, Fiu, and Cir and inhibition by the siderophore enterochelin and its dimeric and trimeric hydrolysis products. Antimicrob Agents Chemother 2005; 49:3083–3086 [View Article] [PubMed]
    [Google Scholar]
  67. Hamidian M, Hawkey J, Holt KE, Hall RM. Genome sequence of Acinetobacter baumannii strain D36, an antibiotic-resistant isolate from lineage 2 of global clone 1. Genome Announc 2015; 3:e01478-15 [View Article] [PubMed]
    [Google Scholar]
  68. Sassone-Corsi M, Nuccio S-P, Liu H, Hernandez D, Vu CT et al. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature 2016; 540:280–283 [View Article] [PubMed]
    [Google Scholar]
  69. Aggarwal SD, Lees JA, Jacobs NT, Bee GCW, Abruzzo AR et al. BlpC-mediated selfish program leads to rapid loss of Streptococcus pneumoniae clonal diversity during infection. Cell Host Microbe 2023; 31:124–134 [View Article] [PubMed]
    [Google Scholar]
  70. Poey ME, Azpiroz MF, Laviña M. Comparative analysis of chromosome-encoded microcins. Antimicrob Agents Chemother 2006; 50:1411–1418 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.001346
Loading
/content/journal/micro/10.1099/mic.0.001346
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error